Cargando…
Prognostic plasma biomarkers of early complications and graft‐versus‐host disease in patients undergoing allogeneic hematopoietic stem cell transplantation
Early complications post hematopoietic stem cell transplantation (HSCT) such as sinusoidal obstruction syndrome (SOS) and graft versus host disease (GVHD) can be life threatening. Although several biomarkers have been identified to correlate with these complications and their response to treatment,...
Autores principales: | Balakrishnan, Balaji, Illangeswaran, Raveen Stephen Stallon, Rajamani, Bharathi M, Pai, Aswin Anand, Raj, Infencia Xavier, Paul, Daniel Zechariah, Lakshmi, Kavitha, Mani, Thenmozhi, Mohanan, Ezhilpavai, Kulkarni, Uday, Devasia, Anup Joseph, NA, Fouzia, Korula, Anu, Abraham, Aby, Srivastava, Alok, Mathews, Vikram, Paczesny, Sophie, George, Biju, Balasubramanian, Poonkuzhali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7116009/ https://www.ncbi.nlm.nih.gov/pubmed/32885223 http://dx.doi.org/10.1002/jha2.26 |
Ejemplares similares
-
Biomarkers for early complications post hematopoietic cell transplantation: Insights and challenges
por: Balakrishnan, Balaji, et al.
Publicado: (2023) -
Metformin pretreatment ameliorates busulfan-induced liver endothelial toxicity during haematopoietic stem cell transplantation
por: Balakrishnan, Balaji, et al.
Publicado: (2023) -
NUDT15 c.415C>T Polymorphism Predicts 6-MP Induced Early Myelotoxicity in Patients with Acute Lymphoblastic Leukemia Undergoing Maintenance Therapy
por: Pai, Aswin Anand, et al.
Publicado: (2021) -
A personalized approach to acute myeloid leukemia therapy: current options
por: Illangeswaran, Raveen Stephen Stallon, et al.
Publicado: (2019) -
Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib in vitro and reduces disease burden in vivo
por: Rajamani, Bharathi M., et al.
Publicado: (2023)